Interleukin-15-transferred cytokine-induced killer cells elevated anti-tumor activity in a gastric tumor-bearing nude mice model

Cell Biology International

Volumn 40, Issue 2, 2016, Pages 204-213

  Peng, Zheng ^a   Liang, Wentao ^a   Li, Zexue ^a   Xu, Yingxin ^a   Chen, Lin ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Anti tumor; Cytokine induced killer cells; Gastric cancer; Interleukin 15; Tumor bearing nude mice model

Indexed keywords

CYTOKINE; INTERLEUKIN 15; RETROVIRUS VECTOR; SODIUM CHLORIDE; ANTINEOPLASTIC AGENT;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOKINE INDUCED KILLER CELL; DRUG CYTOTOXICITY; EMBRYO; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; STOMACH CANCER; STOMACH CARCINOMA; STOMACH TUMOR; TUMOR VOLUME; VIRAL GENE DELIVERY SYSTEM; ANIMAL; APOPTOSIS; BIOSYNTHESIS; DRUG EFFECTS; DRUG SCREENING; GENETICS; IMMUNOLOGY; NATURAL KILLER T CELL; PROCEDURES; RANDOMIZATION; STOMACH NEOPLASMS; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CYTOKINE-INDUCED KILLER CELLS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-15; MALE; MICE; MICE, NUDE; NATURAL KILLER T-CELLS; RANDOM ALLOCATION; STOMACH NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84954390613     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10553     Document Type: Article

References (44)

1. Bielamowicz K, Khawja S, Ahmed N (2013) Adoptive cell therapies for glioblastoma. Front Oncol 3: 275.
2. Castillo EF, Schluns KS (2012) Regulating the immune system via IL-15 transpresentation. Cytokine 59: 479-90.
3. Colombo F, Barzon L, Franchin E, Pacenti M, Pinna V, Danieli D, Zanusso M, Palu G (2005) Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical results. Cancer Gene Ther 12: 835-48.
4. Dey D, Evans GR (2011) Suicide gene therapy by herpes simplex virus-1 thymidine kinase (HSV-TK). Targets in gene therapy. Rijeka, Croatia: InTech.
5. Di Stasi A, Tey S-K, Dotti G, Fujita Y, Kennedy-Nasser A, Martinez C, Straathof K, Liu E, Durett AG, Grilley B (2011) Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med 365: 1673-83.
6. Dougherty CJ, Ichim T, Reznik BN (2008) Assays for development of boris mutants suitable for vaccine development and small molecule inhibitors of wild-type boris. Google Patents.
7. Dubois S, Mariner J, Waldmann TA, Tagaya Y (2002) IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 17: 537-47.
8. Dubois S, Waldmann TA, Muller JR (2006) ITK and IL-15 support two distinct subsets of CD8+ T cells. Proc Natl Acad Sci USA 103: 12075-80.
9. Epardaud M, Elpek KG, Rubinstein MP, Yonekura AR, Bellemare-Pelletier A, Bronson R, Hamerman JA, Goldrath AW, Turley SJ (2008) Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells. Cancer Res 68: 2972-83.
10. Ettinghausen SE, Moore JG, White DE, Platanias L, Young NS, Rosenberg SA (1987) Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients. Blood 69: 1654-60.
11. Higashi K, Hazama S, Araki A, Yoshimura K, Iizuka N, Yoshino S, Noma T, Oka M (2014) A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model. Int J Oncol 45: 1412-20.
12. Hsu C, Abad JD, Morgan RA (2013) Characterization of human T lymphocytes engineered to express interleukin-15 and herpes simplex virus-thymidine kinase. J Surg Res 184: 282-9.
13. Jakel CE, Schmidt-Wolf IG (2014) An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells. Expert Opin Biol Ther 14: 905-16.
14. Jakel CE, Vogt A, Gonzalez-Carmona MA, Schmidt-Wolf IG (2014) Clinical studies applying cytokine-induced killer cells for the treatment of gastrointestinal tumors. J Immunol Res 2014: 897214.
15. Jiang J, Wu C, Lu B (2013) Cytokine-induced killer cells promote antitumor immunity. J Transl Med 11: 83.
16. Jiang J, Xu N, Wu C, Deng H, Lu M, Li M, Xu B, Wu J, Wang R, Xu J, Nilsson-Ehle P (2006) Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells. Anticancer Res 26: 2237-42.
17. June CH (2007) Adoptive T cell therapy for cancer in the clinic. J Clin Invest 117: 1466-76.
18. Kim SW, Kim SJ, Park SH, Yang HG, Kang MC, Choi YW, Kim SM, Jeun S-S, Sung YC (2013) Complete regression of metastatic renal cell carcinoma by multiple injections of engineered mesenchymal stem cells expressing dodecameric TRAIL and HSV-TK. Clin Cancer Res 19: 415-27.
19. Krause SW, Gastpar R, Andreesen R, Gross C, Ullrich H, Thonigs G, Pfister K, Multhoff G (2004) Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells a clinical phase I trial. Clin Cancer Res 10: 3699-707.
20. Ladhams A, Schmidt C, Sing G, Butterworth L, Fielding G, Tesar P, Strong R, Leggett B, Powell L, Maddern G (2002) Treatment of non-resectable hepatocellular carcinoma with autologous tumor-pulsed dendritic cells. J Gastroenterol Hepatol 17: 889-96.
21. Liu W, Guo QL, You QD, Zhao L, Gu HY, Yuan ST (2005) Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823. World J Gastroenterol 11: 3655-9.
22. Martinović KM, Babović N, Džodić R, Jurišić V, Matković S, Konjević G (2015) Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients. J Transl Med 13: 120-34.
23. Matsueda S, Graham DY (2014) Immunotherapy in gastric cancer. World J Gastroenterol 20: 1657-66.
24. Morgan RA, Yang JC, Kitano M, Dudley ME, Laurencot CM, Rosenberg SA (2010) Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol Ther 18: 843-51.
25. Nagaraj S, Ziske C, Schmidt-Wolf IG (2004) Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer. Genet Vaccines Ther 2: 12.
26. Ohtani H, Tamamori Y, Noguchi K, Azuma T, Fujimoto S, Oba H, Aoki T, Minami M, Hirakawa K (2011) Meta-analysis of laparoscopy-assisted and open distal gastrectomy for gastric cancer. J Surg Res 171: 479-85.
27. Palu G, Cavaggioni A, Calvi P, Franchin E, Pizzato M, Boschetto R, Parolin C, Chilosi M, Ferrini S, Zanusso A, Colombo F (1999) Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans. Gene Ther 6: 330-7.
28. Palu G, Pizzato M, Bonaguro R, Colombo F (2000) Gene therapy of glioblastoma multiforme with a bicistronic retroviral vector expressing human IL-2 and HSV-tK. Methods Mol Med 35: 511-22.
29. Pendurthi TK, Parker R, Schlom J, Primus FJ (1990) Lymphokine-activated killer cell cytotoxicity against human colon carcinomas enhanced by monoclonal antibody D612. Int J Cancer 46: 1021-8.
30. Rettinger E, Kuci S, Naumann I, Becker P, Kreyenberg H, Anzaghe M, Willasch A, Koehl U, Bug G, Ruthardt M, Klingebiel T, Fulda S, Bader P (2012) The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells. Cytotherapy 14: 91-103.
31. Schmidt-Wolf I, Negrin RS, Kiem H-P, Blume KG, Weissman IL (1991) Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J Exp Med 174: 139-49.
32. Shamblott MJ, Axelman J, Littlefield JW, Blumenthal PD, Huggins GR, Cui Y, Cheng L, Gearhart JD (2001) Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc Natl Acad Sci USA 98: 113-8.
33. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD (2001) IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410: 1107-11.
34. Stoklasek TA, Schluns KS, Lefrançois L (2006) Combined IL-15/IL-15Rα immunotherapy maximizes IL-15 activity in vivo. J Immunol 177: 6072-80.
35. Takahashi H, Nakada T, Puisieux I (1993) Inhibition of human colon cancer growth by antibody-directed human LAK cells in SCID mice. Science 259: 1460-3.
36. Tamzalit F, Barbieux I, Plet A, Heim J, Nedellec S, Morisseau S, Jacques Y, Mortier E (2014) IL-15. IL-15Ralpha complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells. Proc Natl Acad Sci USA 111: 8565-70.
37. Toomey PG, Vohra NA, Ghansah T, Sarnaik AA, Pilon-Thomas SA (2013) Immunotherapy for gastrointestinal malignancies. Cancer Control 20: 32-42.
38. Vuletic AM, Jovanic IP, Jurisic VB, Milovanovic ZM, Nikolic SS, Tanic NT, Konjevic GM (2015) In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15. Melanoma Res 25: 22-34.
39. Waldmann TA (2006) The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 6: 595-601.
40. Wang F-S, Liu M-X, Zhang B, Shi M, Lei Z-Y, Sun W-B, Du Q-Y, Chen J-M (2002) Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo. World J Gastroenterol 8: 464-8.
41. Wang W, Meng M, Zhang Y, Wei C, Xie Y, Jiang L, Wang C, Yang F, Tang W, Jin X (2014) Global transcriptome-wide analysis of CIK cells identify distinct roles of IL-2 and IL-15 in acquisition of cytotoxic capacity against tumor. BMC Med Genomics 7: 49.
42. Wei C, Wang W, Pang W, Meng M, Jiang L, Xue S, Xie Y, Li R, Hou Z (2014) The CIK cells stimulated with combination of IL-2 and IL-15 provide an improved cytotoxic capacity against human lung adenocarcinoma. Tumour Biol 35: 1997-2007.
43. Xu Y, Hou J, Liu Z, Yu H, Sun W, Xiong J, Liao Z, Zhou F, Xie C, Zhou Y (2011) Gene therapy with tumor-specific promoter mediated suicide gene plus IL-12 gene enhanced tumor inhibition and prolonged host survival in a murine model of Lewis lung carcinoma. J Transl Med 9: 39.
44. Zhu J-L, Gao P, Wang Z-N, Song Y-X, Li A-L, Xu Y-Y, Wang M-X, Xu H-M (2013) Clinicopathological significance of claudin-4 in gastric carcinoma. World J Surg Oncol 11: 150.